Skip to content
Application 207306
- Type
- ANDA
- Sponsor
- CIPLA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ARFORMOTEROL TARTRATE | ARFORMOTEROL TARTRATE | SOLUTION;INHALATION | EQ 0.015MG BASE/2ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 69097-168 | arformoterol tartrate | arformoterol tartrate | Cipla USA Inc. | ANDA | Current |
| 69097-168 | arformoterol tartrate | arformoterol tartrate | Cipla USA Inc. | ANDA | Current |
| 69097-168 | arformoterol tartrate | arformoterol tartrate | Cipla USA Inc. | ANDA | Current |
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 68021 | ORIG | 2021-07-07 |